Citadel Advisors’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$82.9K Buy
270,966
+176,495
+187% +$54K ﹤0.01% 5329
2025
Q1
$26.9K Buy
94,471
+91,403
+2,979% +$26.1K ﹤0.01% 5531
2024
Q4
$1.03K Buy
+3,068
New +$1.03K ﹤0.01% 5837
2024
Q3
Hold
0
6197
2024
Q2
Hold
0
6335
2024
Q1
Hold
0
6446
2023
Q4
Hold
0
6260
2023
Q3
Hold
0
6151
2023
Q2
Hold
0
6111
2023
Q1
Hold
0
6204
2022
Q4
Sell
-15,583
Closed -$7K 6359
2022
Q3
$7K Sell
15,583
-113,607
-88% -$51K ﹤0.01% 5673
2022
Q2
$69K Buy
129,190
+119,183
+1,191% +$63.7K ﹤0.01% 5415
2022
Q1
$10K Sell
10,007
-46,789
-82% -$46.8K ﹤0.01% 6209
2021
Q4
$55K Sell
56,796
-6,823
-11% -$6.61K ﹤0.01% 6133
2021
Q3
$94K Sell
63,619
-14,017
-18% -$20.7K ﹤0.01% 5908
2021
Q2
$127K Buy
77,636
+62,255
+405% +$102K ﹤0.01% 5849
2021
Q1
$28K Buy
+15,381
New +$28K ﹤0.01% 6168
2020
Q4
Hold
0
5304
2020
Q3
Sell
-29,459
Closed -$18K 4942
2020
Q2
$18K Buy
+29,459
New +$18K ﹤0.01% 4498
2020
Q1
Sell
-14,735
Closed -$9K 5046
2019
Q4
$9K Sell
14,735
-27,496
-65% -$16.8K ﹤0.01% 4558
2019
Q3
$41K Buy
42,231
+2,652
+7% +$2.58K ﹤0.01% 4392
2019
Q2
$65K Buy
+39,579
New +$65K ﹤0.01% 4320
2018
Q3
Sell
-114,693
Closed -$57K 4504
2018
Q2
$57K Sell
114,693
-34,761
-23% -$17.3K ﹤0.01% 3897
2018
Q1
$84K Buy
+149,454
New +$84K ﹤0.01% 3661
2017
Q4
Sell
-32,404
Closed -$12K 4060
2017
Q3
$12K Buy
32,404
+8,628
+36% +$3.2K ﹤0.01% 3580
2017
Q2
$10K Sell
23,776
-67,680
-74% -$28.5K ﹤0.01% 3581
2017
Q1
$43K Buy
91,456
+44,246
+94% +$20.8K ﹤0.01% 3425
2016
Q4
$13K Buy
+47,210
New +$13K ﹤0.01% 3498
2016
Q2
Sell
-168,104
Closed -$87K 3596
2016
Q1
$87K Buy
168,104
+155,414
+1,225% +$80.4K ﹤0.01% 2911
2015
Q4
$3K Sell
12,690
-18,195
-59% -$4.3K ﹤0.01% 3839
2015
Q3
$6K Buy
30,885
+8,036
+35% +$1.56K ﹤0.01% 3922
2015
Q2
$9K Buy
22,849
+4,464
+24% +$1.76K ﹤0.01% 3707
2015
Q1
$8K Sell
18,385
-11,419
-38% -$4.97K ﹤0.01% 3680
2014
Q4
$21K Buy
+29,804
New +$21K ﹤0.01% 3584
2014
Q2
Sell
-42,692
Closed -$34K 3564
2014
Q1
$34K Buy
42,692
+27,736
+185% +$22.1K ﹤0.01% 3369
2013
Q4
$15K Buy
+14,956
New +$15K ﹤0.01% 2953